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the clinical decision-making process, a consensus was 
developed. This initiative was endorsed by ESSKA.
Methods A degenerative meniscus lesion was defined 
as a lesion occurring without any history of significant 
acute trauma in a patient older than 35 years. Congenital 
lesions, traumatic meniscus tears and degenerative lesions 
occurring in young patients, especially in athletes, were 
excluded. The project followed the so-called formal con-
sensus process, involving a steering group, a rating group 
and a peer-review group. A total of 84 surgeons and sci-
entists from 22 European countries were included in the 
process. Twenty questions, their associated answers and an 
algorithm based on extensive literature review and clinical 
expertise, were proposed. Each question and answer set 
was graded according to the scientific level of the corre-
sponding literature.
Results The main finding was that arthroscopic partial 
meniscectomy should not be proposed as a first line of 
treatment for degenerative meniscus lesions. Arthroscopic 
partial meniscectomy should only be considered after a 
proper standardised clinical and radiological evaluation and 
when the response to non-operative management has not 
been satisfactory. Magnetic resonance imaging of the knee 
is typically not indicated in the first-line work-up, but knee 
radiography should be used as an imaging tool to support a 
diagnosis of osteoarthritis or to detect certain rare patholo-
gies, such as tumours or fractures of the knee.
Discussion The present work offers a clear framework for 
the management of degenerative meniscus lesions, with 
the aim to balance information extracted from the scien-
tific evidence and clinical expertise. Because of biases and 
weaknesses of the current literature and lack of definition 
of important criteria such as mechanical symptoms, it can-
not be considered as an exact treatment algorithm. It sum-
marises the results of the “ESSKA Meniscus Consensus 
Abstract 
Purpose A degenerative meniscus lesion is a slowly 
developing process typically involving a horizontal cleav-
age in a middle-aged or older person. When the knee is 
symptomatic, arthroscopic partial meniscectomy has been 
practised for a long time with many case series report-
ing improved patient outcomes. Since 2002, several ran-
domised clinical trials demonstrated no additional benefit 
of arthroscopic partial meniscectomy compared to non-
operative treatment, sham surgery or sham arthroscopic 
partial meniscectomy. These results introduced controversy 
in the medical community and made clinical decision-mak-
ing challenging in the daily clinical practice. To facilitate 
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Project” (http://www.esska.org/education/projects) and 
is the first official European consensus on this topic. The 
consensus may be updated and refined as more high-quality 
evidence emerges.
Level of evidence I.
Keywords Meniscus · Degenerative Lesion · Arthroscopic 
partial meniscectomy · Management · Consensus
Introduction
Degenerative meniscus lesions (DMLs) develop slowly and 
typically involve a horizontal cleavage of the meniscus in 
middle-aged or older persons. They are frequent in the gen-
eral population, and their prevalence increases with age, 
ranging from 16% in knees of 50–59 year-old women to 
over 50% in men aged 70–90 years [10]. Magnetic reso-
nance imaging (MRI) will typically identify a linear intra-
meniscus signal [18], often communicating with the articu-
lar surface. This hypersignal is reported to be the result of 
ongoing mucoid degenerative changes. Such a DML can be 
considered as an ageing or degenerative process. Although 
there is a clear correlation between knee osteoarthritis and 
meniscus degeneration, it is sometimes difficult to establish 
a clear line of distinction between these two entities.
Arthroscopic partial meniscectomy (APM) is one of the 
most popular orthopaedic procedures, especially for DMLs, 
and its incidence has been growing in several countries [1, 
26]. Post-operative improvement has been reported, even 
for patients with a DML [6], but some complications or 
failures have also been witnessed [21], and the high risk 
of osteoarthritis after APM remains a concern [27]. Since 
2002, the majority of randomised controlled trials (RCTs) 
dealing with the treatment of DMLs [except Gauffin et al. 
11] demonstrated no additional benefit of APM compared 
to non-operative treatment or sham surgery/sham APM at 
a short- and mid-term follow-up [13, 14, 16, 17, 19, 24, 
30]. However, there is a considerable gap between clinical 
reality and the conclusions of these studies promoting non-
operative treatment to be used as the first line of treatment 
in the daily clinical practice. In Denmark, for instance, the 
overall annual incidence of surgical meniscus procedures 
per 100,000 persons has doubled from 164 in 2000 to 312 
in 2011. A twofold increase was found for patients aged 
between 35 and 55 years and a threefold increase for those 
older than 55 years [26]. This corresponds approximately 
to the same period in which the above-mentioned RCTs 
have been published.
Given the complex clinical reality, running RCTs can 
give rise to bias [7, 8]. For example, patients starting 
out with a conservative treatment for a DML sometimes 
require surgery before the planned follow-up period is 
over. Such a change of the study makes the interpreta-
tion of the results complex and may weaken the conclu-
sion of an RCT, despite its stronger methodological design 
in comparison to studies with a lower level of evidence. 
Nevertheless, these RCTs exist, and despite their weak-
nesses, they give an important message. Well-performed 
RCTs provide a higher level of evidence than case series 
or clinical impressions. The latter, for example, ignore 
placebo and other contextual effects always explain a vari-
able proportion of the treatment outcomes. Bearing this in 
mind, the treatment of a patient with a symptomatic knee 
and a DML should be related both to scientific evidence 
and clinical expertise.
The publication of the above-mentioned RCTs intro-
duced a big controversy in the medical community. This 
was emphasised by B. Reider in his editorial entitled “To 
cut…or not to cut” [20]: “it is not surprising that we ortho-
paedic surgeons like doing orthopaedic surgery…but as 
ethical physicians, we only want to do so when it is the best 
interest of our patients”. In this debate, several editorials 
and letters have been published [5, 9, 28]. These contro-
versial exchanges have not always been useful to the clini-
cian in his/her decision-making process concerning patients 
with a symptomatic knee and a DML. Therefore, there is 
a need for a more uniform and clear consensus. This has 
been underlined in a recent editorial in the KSSTA journal 
where we stated that “the necessity of a consensual process 
becomes clear, founded on the independence of the organ-
isers and with the participation of all interested parties … 
Work of this kind will permit a probable reduction in the 
number of arthroscopic meniscal resections in our coun-
tries in favour of abstention and an improved nosological 
definition of “meniscectomy”, rendering it pertinent and 
efficient” [4].
In order to assist surgeons in their treatment indica-
tions, ESSKA has, therefore, decided to initiate a Euro-
pean Meniscus Consensus Project. The first part, presented 
here, is devoted to DMLs. The complete report of the pro-
ject can be found on the Society’s website (http://www.
esska.org/education/projects). The reader is cautioned that 
this is not a systematic literature review on the topic of 
DML. In addition, this project should be considered as a 
“framework” rather than “strict guidelines”. Its goal was to 
provide a reference frame for the management of DMLs, 
based both on scientific literature and balanced expert 
opinion.
Methods
In this consensus project, a DML was defined as a menis-
cus lesion occurring without a history of a knee trauma in 
a patient older than 35 years. Congenital lesions, traumatic 
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meniscus tears and degenerative lesions occurring in young 
patients, especially in athletes, were excluded. The project 
started in December 2014, using a formal consensus pro-
cess as described by the French National Healthcare Insti-
tution (Haute Autorité de Santé HAS [12]). This process 
was described to be robust, clear and rigorous, as it is based 
on a repetitive evaluation by the following three groups of 
experts (Fig. 1).
The steering group
The steering group was composed by 15 meniscus treat-
ment experts (13 orthopaedic surgeons, one physiotherapist 
and one epidemiologist) and was directed by two chairmen 
(PB and RB). The group had two missions: (1) Define a 
frame for the topic (2) Write down solid arguments based 
on a thorough literature review. Therefore, an exten-
sive search of the literature was performed during Janu-
ary 2000–May 2015 in the following databases: PubMed, 
EMBASE and Medline, as well as the Cochrane Central 
Register of Controlled Trials (CENTRAL) (Wiley Online 
Library, May 2015). The searched combinations of terms 
included: “degenerative meniscus”, “degenerative menis-
cal lesion”, “degenerative meniscus surgery”, “randomised 
control trial”, “knee arthritis”, “lavage”, “debridement”, 
“clinical trial”, “meniscus imaging”, “MRI”, “horizontal 
cleavage”, “intrameniscus signal”, “unstable meniscus 
lesion”, “unstable meniscus tear”, “knee radiography”, 
“mechanical symptom”, “rehabilitation”, “physiotherapy”, 
“intra-articular injection”, “sham”, “placebo”, “hyaluronic 
acid”, “osteonecrosis”, “meniscectomy”, “partial meniscec-
tomy”, “complication”, “extrusion”. Language restriction 
was not set in this search, and all related references were 
also researched. Inclusion criteria were: (1) Level I and II 
studies, (2) human studies, (3) published between January 
2000 and May 2015 and (4) more than four patients in the 
treatment group. All animal or cadaveric studies and stud-
ies about revision surgeries were excluded. For topic(s) 
without strong scientific evidence, we included Level III 
and IV studies. For quality assessment, all eligible stud-
ies were evaluated independently by two reviewers (MO 
and PB) according to the criteria of the Cochrane Hand-
book for Systematic Reviews [15]. A list of questions and 
their related answers (question–answer sets) were defined 
and assorted to the levels of recommendation proposed by 
Shekelle et al. [23] (grade A: high scientific level, grade 
B: scientific presumption, grade C: low scientific level, 
grade D: expert opinion). Both questions with limited 
«scientifically based answers» as well as questions with 
clear «scientific evidence answers» in the current litera-
ture were treated, provided that recommendations were just 
decreased to a lower grade.
Rating Group :  
23 participants 
Identification- Selection 
Analysis –Synthesis 
of the literature 
First draft 
Steering Group :  
15 participants 
1st Rating Round 
Suggestions 
2nd Rating Round 
2nd draft  
Peer Review Group:  
46 participants 
Combined meeting 
Steering Group + Rating Group 
Final manuscript 
Fig. 1  Formal Consensus Project
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The rating group
The rating group was composed of 23 experts from 16 
European countries involved in meniscus surgery in their 
daily practice. The mission of this group was to select and 
evaluate the question–answer sets through a numerical 
grading system. Every expert was asked to evaluate each 
couple by using a 1–9 points grading scale. Their recom-
mendation was supposed to be based on the scientific level 
of the available literature as well as their personal expe-
rience. A value of 1 meant that the rater considered the 
proposal totally inappropriate (or not indicated or unac-
ceptable), whereas a value of 9 indicated that the rater 
considered the proposal totally appropriate (or indicated 
or acceptable). Values of 2–8 represented possible inter-
mediate situations. A proposal was deemed appropriate 
when the value of the median was ≥7, and the scores of 
each rater were ≥5. According to the formal consensus 
rules, low scores were not taken into account when coming 
from only one single rater. The proposals on which mem-
bers of the rating group agreed and those on which they dif-
fered or were undecided were identified by means of votes 
conducted in two rounds and an interim feedback steering 
group meeting.
The peer‑review group
This third and last group was composed of 46 orthopaedic 
surgeons, who perform knee arthroscopies on a daily basis 
and can be considered as representatives of the European 
community of orthopaedic surgeons who take care of pain-
ful knees. They were asked to participate in the consen-
sus initiative through the executive boards of the affiliated 
national subspecialty societies of ESSKA. The mission of 
this group was to evaluate the manuscript draft after the 
grading process of the rating group in order to determine 
the feasibility, accessibility and readability of the proposed 
recommendations.
The manuscript elaboration process
After revision by the rating group, the steering group 
produced a manuscript which was submitted to the peer-
review group. The steering group organised a final plenary 
assembly of both the steering and rating groups to produce 
a final manuscript which was submitted to the peer-review 
group. Finally, the steering group designed complementary 
documents: summary, brochure, keynote for podium pres-
entations and scientific papers. Altogether, the complete 
consensus initiative involved 84 clinicians from 22 Euro-
pean countries. Through this long and complex process, the 
authors aimed at reducing the risk of any single individual 
or country-specific bias in the orthopaedic community and 
at increasing the general acceptance of the initiative due to 
the involvement of a large number of participants.
Results
The question–answer sets
The question–answer sets were related to the four follow-
ing subjects: the background of degenerative meniscus 
lesions (A), their imaging (B) and management (C), as well 
as a diagnostic and therapeutic algorithm (D). Background, 
imaging and management sections include questions, their 
respective answers and the proposed grade of the answers. 
To support each question and answer set, an extensive lit-
erature review was provided by the experts. For practical 
reasons, the extensive list of references (125 references) is 
not provided in this article. It can be downloaded from the 
ESSKA website (http://www.esska.org/education/projects).
Results of the grading process
After the second rating round, the median score for each 
question–answer set ranged between 7.5 and 8.9. All raters 
scored at least five or more for each proposed question–
answer couple, except one rater who scored <5 for 12 out of 
20 questions. According to the formal consensus rules, these 
isolated low scores were not taken into account. All the 
question–answer sets were thus considered as appropriate.
Background
What is a degenerative meniscus lesion?
A degenerative meniscus lesion is a slowly developing 
lesion, typically involving a horizontal cleavage of the 
meniscus in a middle-aged or older person. Such menis-
cus lesions are frequent in the general population and are 
often incidental findings on knee MRI (Fig. 2). The patho-
genesis is not fully understood. There is often no clear 
history of an acute knee injury (Grade B).
Which MRI criteria characterise a degenerative meniscus 
lesion?
A degenerative meniscus lesion is usually characterised 
by linear intrameniscus MRI signal (including a compo-
nent with horizontal pattern) often communicating with 
the inferior meniscus surface on at least two image slices. 
A more complex tear pattern in multiple configurations 
may also occur. The most common location of a degener-
ative meniscus lesion is the body and (or) posterior horn 
of the medial meniscus (Grade B).
339Knee Surg Sports Traumatol Arthrosc (2017) 25:335–346 
1 3
What is the prevalence of degenerative meniscus lesions?
The prevalence of meniscus lesions (on the knee level) in 
the general population [intrameniscus signal extending to 
surface according to the two-slice touch rule (Fig. 3)] is: 
1. Age 50–59 years ≈ 25%;
2. Age 60–69 years ≈ 35%;
3. Age 70–79 years ≈ 45%;
4. Patients with knee osteoarthritis ≈75–95%.
Please note that the estimates above do not include 
meniscus destruction/maceration, i.e. absence of normal 
meniscus tissue, which is also a frequent finding particu-
larly in elderly women (Grade B).
Do degenerative meniscus lesions cause knee symptoms?
There is very limited evidence that pain in the degenera-
tive knee is directly attributable to a degenerative meniscus 
lesion even if the lesion is considered to be unstable. Great 
caution must be taken before arriving at the conclusion that 
the degenerative meniscus lesion is the direct cause of the 
patients’ knee symptoms (Grade B).
Does an unstable degenerative meniscus lesion cause knee 
symptoms?
While there is limited support in the literature that degen-
erative meniscus lesions considered to be unstable, e.g. flap 
tears, are truly causing knee symptoms, it is still plausible 
that, in some patients, torn meniscus parts from the degen-
erative lesion (by its displacement) may cause knee joint 
symptoms (Grade C).
What are the consequences of a degenerative meniscus 
lesion in the knee?
Loss of meniscus function may negatively affect the knee 
in the long term. Therefore, in many people, the degenera-
tive meniscus lesion (which may impair the force transmis-
sion and load distribution capabilities of the meniscus) is a 
Fig. 2  Development of an intrameniscus signal into a horizontal cleavage lesion in the posterior horn of a medial meniscus over a period of four 
years captured on repeat 3-Tesla knee MRI (courtesy of M Englund)
Fig. 3  Prevalence of meniscus 
lesions and destruction in a 
randomly recruited population-
based sample. a Meniscus tear 
and b meniscus destruction 
(not classified as a tear) in the 
right knee of men (n = 426) 
and women (n = 565) aged 
50–90 from Framingham, MA, 
USA. The diagnosis was based 
on MRI. Participants were not 
selected on the basis of knee or 
other joint problems. Error bars 
show the 95% CI (reprinted 
with permission from New Engl 
J Med)
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feature indicative of a knee joint with (or at increased risk 
of) developing osteoarthritis (Grade B).
Are degenerative meniscus lesions a cause or consequence 
of knee osteoarthritis?
The answer to this question is still unclear. However, one 
causal pathway does not necessarily exclude the other, i.e. 
one phenotype of knee osteoarthritis may start with menis-
cus degradation and degenerative lesion leading to loss of 
meniscus function and osteoarthritis development. In turn, 
osteoarthritis and its general degradation of the knee joint, 
involving multiple structures, may also cause degenerative 
meniscus lesions and extrusion that further accelerate struc-
tural progression of the disease (Fig. 4) (Grade B).
Imaging
What is the role of knee radiographs in the assessment 
of middle‑aged or older patients with a painful knee?
Knee radiography should be used as a first-line imaging 
tool to support a diagnosis of osteoarthritis or to detect cer-
tain rarer pathologies of the knee. Therefore, at least a pos-
terior-anterior weight-bearing semi-flexed knee radiograph 
and a lateral view should be included in the work-up of the 
middle-aged or older patient with knee pain (Grade B).
How should we make the diagnosis of knee osteoarthritis 
on a daily practical basis?
The clinical diagnosis of osteoarthritis can typically be 
made on the basis of the duration and character of the 
knee joint symptoms, patient history (including the pres-
ence of strong risk factors for osteoarthritis such as age, 
limb malalignment, obesity, heredity, prior knee injuries 
and surgeries) and findings from clinical examination. In 
the orthopaedic setting, weight-bearing semi-flexed knee 
radiographs (such as the Lyon Schuss or Rosenberg view) 
should be included in the work-up of the middle-aged 
or older patient with knee pain. A skyline patella view 
is also important for the detection of radiographic evi-
dence of patella-femoral osteoarthritis. Please note that 
plain knee radiography does not necessarily capture early 
stages of symptomatic knee osteoarthritis (Grade B).
What is the role of knee MRI in the assessment of a 
middle‑aged or older patient with a painful knee?
Knee MRI is typically not indicated in the first-line 
work-up of the middle-aged or older patients with knee 
joint symptoms. However, knee MRI may be indicated 
in selected patients with refractory symptoms or in the 
presence of “warning flags” or localised symptoms indi-
cating a rarer disease that needs to be ruled out, e.g. 
Fig. 4  Meniscus pathway to 
knee osteoarthritis
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osteonecrosis. Hence, if a surgical indication is consid-
ered, based on history, symptoms, clinical exam and knee 
radiography, knee MRI may be useful to identify struc-
tural knee pathologies that may (or may not) be relevant 
for the symptoms (Grade B).
Management
Are functional outcomes of arthroscopic partial 
meniscectomy (APM) and non‑operative treatment 
different, based on osteoarthritic (OA) status?
No study compared OA knees with non-OA knees regard-
ing the treatment. Thus, data are lacking on the relationship 
between the duration of symptoms, stage and location of 
OA, etc., and the treatment outcomes (Grade D) (Table 1).
What is the patient population defined by the RCT studies?
Based on RCT inclusion criteria, the studies include 
patients with:
•	 Age ≥35 years (Grade A).
•	 Male or female (Grade A).
•	 Daily or almost daily knee pain >1 month (Grade A).
•	 Medial or lateral degenerative meniscus lesion (Grade 
A).
•	 With or without mechanical symptoms (Grade A).
What does non‑operative treatment mean?
1. No evidence of which time/type of non-operative treat-
ment should be proposed.
2. In the current literature, RCTs have proposed various 
rehabilitation protocols, however, non-operative treat-
ment could also consist of NSAID (if no contraindica-
tions), intra-articular injection,1, physiotherapy and/or 
home exercises for 3–6 months (Grade B).
It is important to note that no study has focused on func-
tional outcomes of non-operative treatment vs placebo (or 
nothing).
What is the rate of conversion to surgery in those patients 
undergoing non‑operative treatment?
Non-operative treatment is converted to surgery (cross-
over) in 0–35% of the patients (Grade A).
This cross-over rate has to be compared to the rate of 
arthroscopic treatment failure.
Is the concept of an unstable meniscus useful for indicating 
meniscectomy (locking, clicking, MRI flap, etc.)?
There are controversies regarding the definition and role of 
mechanical symptoms as an indication for APM. The defi-
nition of “mechanical symptoms” remains unclear and fur-
ther investigations are needed, as it may cover a wide range 
of symptoms with different severity and frequency. In the 
RCT by Gauffin et al. [11], patients’ history of symptoms 
(i.e. mechanical symptoms or acute onset of symptoms) did 
not affect outcomes (but patients with a joint locking last-
ing longer than 2 s more than once a week were excluded). 
Pooled results of all RCTs reveal very limited added benefit 
of APM for degenerative meniscus regardless of pre-oper-
ative symptoms (fixed locking knee or knee with recurrent 
catching symptoms excluded) (Grade A).
Sihvonen et al. [25] did not find any benefits over sham APM 
to relieve knee catching or occasional locking. (Grade A).
Indication for early APM depends on the intensity and 
frequency of mechanical symptoms, as well as a thorough 
clinical examination (Fig. 5) (Grade D).
What outcomes can be expected after arthroscopic partial 
meniscectomy (APM)?
1. Improvement of functional outcomes can be expected 
after APM (Grade A).
2. Most of the RCTs found no difference in terms of clin-
ical outcomes after surgery compared to non-operative 
treatment (Grade A).
3. When surgical treatment is proposed after a non-oper-
ative treatment failure, APM will result in similar but 
not superior results than successful non-operative treat-
ment (Grade A).
1 The benefit or risk of corticoid intra-articular injection has to be 
discussed regarding the risk of hidden osteonecrosis. Efficacy of hya-
luronic acid injection is controversial.
Table 1  Two RCT’s specifically focused on OA knees [17, 19] and 
five on degenerative meniscus lesions without OA: similar results
APM arthroscopic partial meniscectomy, PT Physiotherapy, KL Kell-
gren–Lawrence classification
References Inclusion criteria 
(arthritis)
Conclusion
Moseley et al. [19] KL ≤ 4 Debridement = Sham
Kirkley et al. [17] KL 2–4 Debridement = PT
Herrlin et al. [13, 14] Al ≤ 1 APM = PT
Katz et al. [16] KL ≤ 1 APM = PT
Yim et al. [30] KL ≤ 1 APM = PT
Sihvonen et al. [22] KL ≤ 1 APM = Sham-
Gauffin et al. [11] KL ≤ 2 + Mechani-
cal symptoms
APM + PT > PT
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4. Three to six percent of patients will require another 
surgical procedure in the year following APM (Grade 
A).
5. Various predictive factors of poor results or treatment 
failures have been described in the current literature 
(increased BMI, lateral side, chondral damage, bone 
marrow oedema, meniscus extrusion (Fig. 6) and total 
or subtotal meniscectomy (Grade C).
The group wants to state that:
The previous consensus statements refer to RCTs with 
Per-Protocol analyses. While mid-term outcomes may 
be similar, short-term outcomes (<12 months) might be 
better with APM than with non-operative treatment. The 
indication for early APM may also depend on the inten-
sity and frequency of mechanical symptoms, as well as 
physical evaluation (Grade D).
What is the rate of surgical complications after meniscus 
resection?
The rate of surgical complication is low (0.27–2.8%) 
(Grade A).
After APM, the rate of complications is dependent on 
laterality, i.e. a lateral meniscectomy is associated with a 
higher rate of complications than a medial one (Grade A).
What is the risk of osteoarthritis after meniscus resection?
1. Patients treated with APM for degenerative menis-
cus lesion present a higher risk for symptomatic knee 
osteoarthritis compared to patients with normal knee 
(healthy subjects). Risk of OA is higher on the lateral 
side (Grade C).
2. Patients with a total meniscectomy (removal of the 
peripheral rim) present a higher risk for symptomatic 
knee osteoarthritis compared to patients with partial 
meniscectomy (Grade C).
3. Cartilage damage or bone marrow lesions prior to 
APM are major factors of poor outcomes (Grade C).
4. Meniscus extrusion (Fig. 6) is associated with local 
osteonecrosis after APM (Grade C).
Is there a place for arthroscopic lavage (or 
lavage and debridement: arthroscopic procedure 
including degenerative (meniscus/chondral) and/or 
synovial tissue debridement?) for OA knees?
There is no place for arthroscopic lavage (or debridement) 
for painful knees with osteoarthritis (K/L ≥ 2). RCT’s 
have shown that debridement/lavage has little, if any, effect 
on patients’ short-terms reported outcomes, satisfaction or 
pain compared to non-operative treatment (Grade A).
Debridement might be indicated for young patients suf-
fering from considerable mechanical symptoms (Grade D).
When should arthroscopic partial meniscectomy (APM) be 
proposed?
1. Surgery should not be proposed as a first line of treat-
ment of DMLs (Grade A).
Fig. 5  Medial meniscus flap subluxated in the tibial gutter with bony 
impingement. This kind of specific degenerative meniscus lesion may 
be associated with significant mechanical symptoms and pain
Fig. 6  Medial meniscus extrusion (>3 mm) demonstrating an early 
osteoarthritic stage (MRI: coronal view; T2 FS)
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2. APM may be proposed after 3 months and persistent 
pain and/or mechanical symptoms related to a DML 
with normal X-rays but an abnormal MRI (Grade III 
meniscus lesion). The patient has to be informed about 
chances of successful outcomes and risks of either 
method (Grade B).
3. Surgery can be proposed earlier for patients presenting 
considerable mechanical symptoms. The patient has 
to be informed of chances and risks of either method 
(Grade D).
However, the steering group wants to state that mechanical 
symptoms cannot be clearly defined according to the cur-
rent literature.
4. No arthroscopic surgery should be proposed for a DML 
with advanced OA on weight-bearing radiographs 
(Grade A).
An exception should be discussed for young patients with 
considerable symptoms.
Algorithm (Fig. 7)
Because of the absence of studies defining the optimal tim-
ing between the onset of symptoms, the beginning of non-
operative treatment and the surgical decision following 
non-operative treatment failure, 3 months after the onset of 
the symptoms, should be considered as a reasonable delay 
before the decision to proceed with APM is made. This 
time corresponds to the mean period between non-opera-
tive treatment and conversion to APM in RCT(s) (Grade 
A). Three to six months should elapse after the onset of 
symptoms before any surgery is proposed to a patient suf-
fering from non-locked, non-arthritic knee pain due to a 
DML (Grade A).
Indication for surgery may be considered earlier if the 
patient presents with considerable mechanical symptoms 
(such as lack of range of motion; daily joint catching; and 
joint locking for more than 2 s over at least 1 week) (Grade 
D).
Discussion
The main finding of the European consensus in the treat-
ment of patients with a symptomatic knee and a DML was 
that APM should not be proposed as a first-line treatment. 
The main reason is that the patient’s symptoms may not 
necessarily relate to the actual DML but to more unspecific 
joint or joint line pain related to early onset osteoarthritis. 
APM should only be proposed after a proper standardised 
clinical and radiological evaluation. When investigating 
knee joint symptoms for a middle-aged or older patient, 
MRI is typically not indicated in the first-line work-up due 
to its high cost and the inherent and high risk of findings 
which are not related to the clinical problem [10]. In the 
daily clinical orthopaedic setting, knee radiographs should 
be used as an imaging tool to support a diagnosis of oste-
oarthritis or to detect certain rarer pathologies such as 
tumours or fractures of the knee.
This consensus process bears some limitations. First, we 
based our rationale and answers on available scientific lit-
erature: RCTs—as good as they may be—have their own 
biases and weaknesses [7]. RCTs including sham proce-
dures do have a very elegant design since they eliminate 
the potential placebo effect of the arthroscopic procedure, 
but they do not correspond to daily clinical practice. Sec-
ond, some clinical situations or signs are difficult to define 
with precision, both in the literature and in the daily clini-
cal practice. “Mechanical symptoms” have not been exactly 
defined so far. They may be considered a key factor in the 
surgical decision-making process potentially leading to 
controversial conclusions. Gauffin et al. [11] found better 
outcomes in the surgery group, independent of the pres-
ence of “mechanical symptoms” (catching, locking knee 
less than once a week). Sihvonen et al. [25] compared out-
comes of APM and sham surgery, based on the presence or 
absence of pre-operative mechanical symptoms. Mechani-
cal symptoms were defined by patients’ self-report as a sen-
sation of catching or locking: true locked knees or recently 
locked knees were excluded. Mechanical symptoms were 
reported in 49% of the entire cohort. In their post hoc anal-
ysis, arthroscopic partial meniscectomy had no benefit over 
sham APM to relieve knee catching or occasional lock-
ing. The facts that only one-fourth of the patients showed 
a positive McMurray test, and conversely 49% of the 
patients reported mechanical symptoms, suggest that there 
is a need for further definition of the mechanical symp-
toms and description of the size, type and location of the 
meniscus tear [29]. In the same way, the timing to consider 
arthroscopic surgery can be a source of controversy. Three 
months from the onset of symptoms was agreed on as a 
general rule as it is the time generally adopted in the RCTs.
Third, a consensus, as good as it may be, is not the only 
factor which will influence surgeons and patients treat-
ment decisions. There are many “peripheral” practical 
constraints such as the myth “I always did so, I learned 
to do so” [2], the skill and simplicity of the procedure or 
the societal pressure (i.e. time to return to sports/work 
or medico-economic constraints that are highly variable 
between European countries and may orientate the deci-
sion in different ways). These “peripheral” constraints 
may limit the impact of a consensus but should not mod-
ify its main messages that non-surgical options should 
be the first-in-line treatment and that standardised clini-
cal and imaging evaluation is needed before proposing an 
APM. Despite its inherent limitations, this work does not 
aim to provide a strict guideline. It should rather reflect a 
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clear framework in the management of a DML with well-
balanced information, based on the currently available 
scientific evidence and the clinical expertise of 84 experi-
enced European practitioners and scientists.
Finally, a consensus is not a final statement. It can be 
completed or modified with time according to the evolu-
tion of the specialty and as new evidence emerges [3, 22]. 
As such, the present work is neither a systematic literature 
Fig. 7  Algorithm for the 
management of Degenerative 
Meniscus Lesions
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review, nor a formal meta-analysis, but the first European 
orthopaedic consensus initiative in the field of meniscus 
lesions. Medical professionals from a total of 22 Euro-
pean countries were involved in an independent and well-
defined process, allowing control and feedback regarding 
20 question–answer sets and an algorithm. Despite geo-
graphic and medico-economic differences among those 
physicians, all questions and answers eventually reached 
a high degree of consensus. The findings will hopefully 
assist every orthopaedic clinician in their decision-making 
when confronted with patients with a DML in a sympto-
matic knee.
Conclusion
The main finding of this first European consensus in the 
treatment of patients with a symptomatic knee and a degen-
erative meniscus lesion was that arthroscopic partial menis-
cectomy should not be proposed as a first-line treatment. 
The main reason is that the patient’s symptoms are not nec-
essarily related to the degenerative meniscus lesion, but to 
more unspecific pain related to early osteoarthritis. Arthro-
scopic partial meniscectomy should only be proposed after 
a standardised clinical and radiological evaluation.
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